SiNON Nano Sciences

📍 Boston, United States🗓 Founded 2015👥 6 employees💰 Last funded Jan 2022
Biotechnology Research🌐 sinontx.com
Website LinkedIn
SiNON Therapeutics patented Carbon NanoDots (CNDsTM) are a drug delivery system with a novel release mechanism that allows for targeted treatment for brain tumors and other neurological diseases. At SiNON Therapeutics we have developed a tunable, platform delivery system that is engineered to encapsulate multiple different therapeutics, including biologics, up to 500kD, and deliver them across the blood-brain barrier (BBB) to treat neurological diseases. Because our CNDs will open only at the site of the tumor and not at healthy tissues, we can deliver higher doses with less overall toxicity for increased therapeutic efficacy. It has been shown that 30-40% of cancers metastasize to the brain yet due to the fact that only 2% of therapies can cross the BBB, the survival rate for patients with brain cancers is only 34%. Our mission is to give hope to thousands of patients suffering from brain tumors that presently have few options for life-saving treatments.
2
Total investors
0
Early stage
1
Mid stage
1
Late stage
2015
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in SiNON Nano Sciences?
SiNON Nano Sciences has 2 investors on record on gritt.io, 1 mid-stage and 1 late-stage investors.
When did SiNON Nano Sciences last raise funding?
The most recent investment in SiNON Nano Sciences recorded on gritt.io was in January 2022.
When was SiNON Nano Sciences founded?
SiNON Nano Sciences was founded in 2015.
What industry is SiNON Nano Sciences in?
SiNON Nano Sciences operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is SiNON Nano Sciences based?
SiNON Nano Sciences is headquartered in Boston, United States.